Next, we performed a multivariate Cox analysis of RhoF expression in AML patients who received intensive chemotherapy, and found that a high level of RhoF expression was an independent risk factor for worse OS (HR =1.770, 95% CI: 1.013-3.092, P =0.045) (Table 6). This evidence concerns the gene RHOF and acute myeloid leukemia.